| 000 | 00000nam 2200000za 4500 |
| 001 | 9.645764 |
| 003 | CaOODSP |
| 005 | 20241115081750 |
| 007 | ta |
| 008 | 150407|1995||||xxc||||| f|0| 0 eng d |
| 020 | |a0-662-21711-X |
| 040 | |aCaOODSP|beng |
| 043 | |an-cn--- |
| 086 | 1 |aH42-2/66-1995E |
| 110 | 1 |aCanada. |bDrugs Directorate. |
| 245 | 14|aThe role of surrogate markers of HIV infection / |cby C. M. Tsoukas. |
| 260 | |aOttawa - Ontario : |bHealth Canada. |c1995. |
| 300 | |a47p. : |breferences, tables ; |c28 cm. |
| 500 | |aContents: Introduction.--Pathophysiology.--Serologic T cell activation markers.--Serologic B cell activation markers.--Antibodies to HIV.--Other antibodies.--Other serologic markers.--Antigen markers.--Cell surface T cell activation markers.--CD4+ T cells.--Discussion and recommendations.--Glossary.--References. |
| 563 | |aSoftcover |
| 590 | |a96-05|b1996-02-02 |
| 690 | 07|aAIDS (disease)|2gcpds |
| 720 | 1 |aTsoukas, C. M. |
| 775 | 08|tLe rôle des marqueurs substituts de l'infection à VIH / |w(CaOODSP)9.679394 |
| 776 | 0#|tThe role of surrogate markers of HIV infection : |w(CaOODSP)9.695832 |